$7.59
0.8612.78%
À la fermeture: Nov 21, 4:00 PM EST
$7.59
N/A
Après les heures de négociation: 7:59 PM EST
Comments
Loading...
Rapport sur les intérêts à découvert
L'intérêt à découvert sur ARS Pharmaceuticals Inc (NASDAQ:SPRY) a augmenté lors de la dernière période de déclaration, augmentant de en hausse de 18.96M à 19.76M. Cela représente 32.56% des actions disponibles au public de l'entreprise.
Sur la base du volume moyen récent de 1.66M actions échangées par jour, il faudrait 11.89 jour(s) aux détenteurs de cet intérêt à découvert pour clôturer leurs positions sans faire monter brusquement le cours de l'action.
Intérêt à court terme
19.76M
Intérêt à court terme %
32.6%
Jours de couverture
11.89
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
SPRY | ARS Pharmaceuticals, Inc. Comm | 10/31/2025 | 11/11/2025 | 32.56% | 60,676,488 | 19,756,847 | 1,662,251 | 11.89 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 10/15/2025 | 10/24/2025 | 31.27% | 60,654,214 | 18,964,276 | 2,607,655 | 7.27 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 09/30/2025 | 10/09/2025 | 35.76% | 60,654,214 | 21,690,186 | 2,583,916 | 8.39 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 09/15/2025 | 09/24/2025 | 35.58% | 60,654,214 | 21,583,515 | 3,535,411 | 6.1 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 08/29/2025 | 09/10/2025 | 34.69% | 60,654,214 | 21,041,326 | 2,600,064 | 8.09 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 08/15/2025 | 08/26/2025 | 29.29% | 60,654,214 | 17,765,896 | 1,861,836 | 9.54 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 07/31/2025 | 08/11/2025 | 25.55% | 60,041,438 | 15,339,705 | 1,291,962 | 11.87 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 07/15/2025 | 07/24/2025 | 24.76% | 60,041,438 | 14,864,141 | 1,251,652 | 11.88 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 06/30/2025 | 07/10/2025 | 26.30% | 60,041,438 | 15,789,752 | 1,991,557 | 7.93 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 06/13/2025 | 06/25/2025 | 27.61% | 60,041,438 | 16,577,058 | 932,688 | 17.77 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 05/30/2025 | 06/10/2025 | 28.54% | 60,041,438 | 17,135,687 | 1,505,653 | 11.38 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 05/15/2025 | 05/27/2025 | 30.36% | 60,041,438 | 18,230,628 | 1,462,795 | 12.46 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 04/30/2025 | 05/09/2025 | 31.79% | 52,626,556 | 16,727,585 | 1,246,232 | 13.42 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 04/15/2025 | 04/25/2025 | 31.28% | 52,626,556 | 16,461,184 | 2,019,839 | 8.15 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 03/31/2025 | 04/09/2025 | 32.59% | 52,626,556 | 17,150,346 | 2,621,785 | 6.54 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 03/14/2025 | 03/25/2025 | 36.92% | 52,626,556 | 19,429,266 | 1,318,622 | 14.73 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 02/28/2025 | 03/11/2025 | 36.76% | 51,692,227 | 19,003,671 | 1,245,803 | 15.25 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 02/14/2025 | 02/26/2025 | 31.89% | 51,692,227 | 16,483,868 | 1,157,920 | 14.24 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 01/31/2025 | 02/11/2025 | 28.38% | 51,692,227 | 14,670,470 | 1,405,708 | 10.44 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 01/15/2025 | 01/27/2025 | 28.65% | 51,692,227 | 14,810,932 | 1,379,774 | 10.73 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 12/31/2024 | 01/10/2025 | 26.46% | 51,692,227 | 13,675,218 | 1,449,691 | 9.43 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 12/13/2024 | 12/24/2024 | 24.49% | 51,692,227 | 12,656,935 | 1,049,459 | 12.06 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 11/29/2024 | 12/10/2024 | 26.37% | 51,692,227 | 13,629,789 | 891,556 | 15.29 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 11/15/2024 | 11/26/2024 | 26.80% | 51,692,227 | 13,852,113 | 1,610,826 | 8.6 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 10/31/2024 | 11/11/2024 | 24.49% | 51,448,361 | 12,597,445 | 928,508 | 13.57 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 10/15/2024 | 10/24/2024 | 23.16% | 51,448,361 | 11,915,667 | 786,205 | 15.16 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 09/30/2024 | 10/09/2024 | 21.57% | 51,448,361 | 11,097,485 | 1,070,102 | 10.37 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 09/13/2024 | 09/24/2024 | 22.62% | 51,448,361 | 11,637,226 | 915,086 | 12.72 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 08/30/2024 | 09/11/2024 | 21.30% | 51,448,361 | 10,960,219 | 1,551,924 | 7.06 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 07/31/2024 | 08/09/2024 | 19.29% | 51,448,361 | 9,925,990 | 587,738 | 16.89 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 07/15/2024 | 07/24/2024 | 17.00% | 51,402,008 | 8,738,917 | 723,751 | 12.07 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 06/28/2024 | 07/10/2024 | 13.39% | 51,402,008 | 6,881,590 | 1,028,228 | 6.69 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 06/14/2024 | 06/26/2024 | 13.32% | 51,402,008 | 6,848,914 | 400,019 | 17.12 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 05/31/2024 | 06/11/2024 | 13.27% | 51,402,008 | 6,818,939 | 353,757 | 19.28 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 05/15/2024 | 05/24/2024 | 13.37% | 51,402,008 | 6,869,975 | 439,580 | 15.63 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 04/30/2024 | 05/09/2024 | 12.41% | 51,402,008 | 6,380,357 | 478,251 | 13.34 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 04/15/2024 | 04/24/2024 | 11.84% | 51,401,146 | 6,087,282 | 550,728 | 11.05 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 03/28/2024 | 04/09/2024 | 9.15% | 60,093,120 | 5,499,624 | 1,199,083 | 4.59 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 03/15/2024 | 03/26/2024 | 7.08% | 60,093,120 | 4,254,773 | 737,973 | 5.77 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 02/29/2024 | 03/11/2024 | 7.68% | 60,006,529 | 4,609,565 | 1,017,649 | 4.53 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 01/31/2024 | 02/09/2024 | 8.16% | 59,588,818 | 4,861,658 | 314,374 | 15.46 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 01/12/2024 | 01/24/2024 | 11.65% | 59,588,818 | 6,942,449 | 279,959 | 24.8 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 12/29/2023 | 01/10/2024 | 11.69% | 59,588,818 | 6,968,061 | 332,577 | 20.95 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 12/15/2023 | 12/27/2023 | 11.21% | 59,588,818 | 6,677,214 | 458,662 | 14.56 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 11/30/2023 | 12/11/2023 | 10.12% | 59,588,818 | 6,029,962 | 493,509 | 12.22 | |
SPRY | ARS Pharmaceuticals, Inc. Comm | 11/15/2023 | 11/27/2023 | 9.96% | 59,588,818 | 5,936,549 | 1,005,979 | 5.9 |
À la recherche des actions les plus vendues à découvert?